An in-house study of six patients with EDS / POTS / Dysautonomia and vascular fibrosis run to find out if abnormal lipo(a) was the cause of their vascular abnormalities. Normal levels were found, so research quickly moved in other directions.
Evaluation of lipo(a) in patients with vascular fibrosis and EDS/POTS/Dysautonomia
by Dr. Diana Driscoll, Optometrist | Jan 31, 2021 | Clinical Trial: Status: Completed | 0 comments